Rapport Therapeutics Inc. Common Stock (RAPP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rapport Therapeutics Inc....

    NASDAQ: RAPP · Real-Time Price · USD
    28.78
    0.24 (0.84%)
    At close: Oct 03, 2025, 3:59 PM

    Rapport Therapeutics Common Stock Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Net Income
    		 -26.73M -24.06M -19.98M -17.54M -18.12M -22.67M -13.52M -8.71M -6.41M -6.15M
    Depreciation & Amortization
    		 252K 244K 260K 219K 208K 152K 53K 23K 21K 15K
    Stock-Based Compensation
    		 4.39M 4.04M 3.21M 3.18M 2.35M 1.49M 998K 859K 945K 723K
    Other Working Capital
    		 -4.4M -618K 693K 3.23M -217K -2.02M 1.22M 1.65M -1.15M -422K
    Other Non-Cash Items
    		 391K -25K 725K -5.56M -670K 6.57M 167K 119K 987K 1.78M
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 -3.37M -433K 1.34M 3.28M -123K -3.16M 1.94M 2.28M -1.15M -422K
    Operating Cash Flow
    		 -25.07M -20.24M -14.45M -16.41M -16.35M -17.61M -10.36M -5.42M -6.6M -4.8M
    Capital Expenditures
    		 -22K -291K -226K -140K -967K -1.07M -1.44M -52K -86K -61K
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 -12.95M -43.67M -84.56M -113.51M -138.43M -44.8M -77.22M n/a n/a n/a
    Sales Maturities Of Investments
    		 35.48M 64.56M 116.72M 56.84M 32.29M 3.95M n/a n/a n/a n/a
    Other Investing Acitivies
    		 92K 436K n/a 3.77M n/a n/a n/a n/a n/a n/a
    Investing Cash Flow
    		 22.6M 21.03M 31.93M -53.04M -107.1M -41.93M -78.66M -52K -86K -61K
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a -1K n/a n/a n/a n/a n/a -4K n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a 221.63M n/a 283K -283K -134K 58K -40K -18K
    Financial Cash Flow
    		 -63K 5K 7K -1.39M 159.35M 63.66M -140K 85.36M -90K 60.01M
    Net Cash Flow
    		 -2.54M 799K 17.49M -70.85M 35.9M 4.12M -89.16M 79.88M -6.78M 55.14M
    Free Cash Flow
    		 -25.09M -20.53M -14.67M -16.55M -17.32M -18.69M -11.79M -5.48M -6.68M -4.86M

    Add to Watchlist